These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20181950)

  • 1. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.
    Borikova AL; Dibble CF; Sciaky N; Welch CM; Abell AN; Bencharit S; Johnson GL
    J Biol Chem; 2010 Apr; 285(16):11760-4. PubMed ID: 20181950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
    Stockton RA; Shenkar R; Awad IA; Ginsberg MH
    J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling.
    Richardson BT; Dibble CF; Borikova AL; Johnson GL
    Biol Chem; 2013 Jan; 394(1):35-42. PubMed ID: 23096573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
    McDonald DA; Shenkar R; Shi C; Stockton RA; Akers AL; Kucherlapati MH; Kucherlapati R; Brainer J; Ginsberg MH; Awad IA; Marchuk DA
    Hum Mol Genet; 2011 Jan; 20(2):211-22. PubMed ID: 20940147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
    Pagenstecher A; Stahl S; Sure U; Felbor U
    Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.
    Cuttano R; Rudini N; Bravi L; Corada M; Giampietro C; Papa E; Morini MF; Maddaluno L; Baeyens N; Adams RH; Jain MK; Owens GK; Schwartz M; Lampugnani MG; Dejana E
    EMBO Mol Med; 2016 Jan; 8(1):6-24. PubMed ID: 26612856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postzygotic mosaicism in cerebral cavernous malformation.
    Rath M; Pagenstecher A; Hoischen A; Felbor U
    J Med Genet; 2020 Mar; 57(3):212-216. PubMed ID: 31446422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
    McDonald DA; Shi C; Shenkar R; Gallione CJ; Akers AL; Li S; De Castro N; Berg MJ; Corcoran DL; Awad IA; Marchuk DA
    Hum Mol Genet; 2014 Aug; 23(16):4357-70. PubMed ID: 24698976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.
    Shenkar R; Shi C; Rebeiz T; Stockton RA; McDonald DA; Mikati AG; Zhang L; Austin C; Akers AL; Gallione CJ; Rorrer A; Gunel M; Min W; De Souza JM; Lee C; Marchuk DA; Awad IA
    Genet Med; 2015 Mar; 17(3):188-196. PubMed ID: 25122144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.
    Wüstehube J; Bartol A; Liebler SS; Brütsch R; Zhu Y; Felbor U; Sure U; Augustin HG; Fischer A
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12640-5. PubMed ID: 20616044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
    Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of the junctional anchorage of the cerebral cavernous malformations complex.
    Gingras AR; Liu JJ; Ginsberg MH
    J Cell Biol; 2012 Oct; 199(1):39-48. PubMed ID: 23007647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
    Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
    Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.
    Akers AL; Johnson E; Steinberg GK; Zabramski JM; Marchuk DA
    Hum Mol Genet; 2009 Mar; 18(5):919-30. PubMed ID: 19088123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variations within KRIT1/CCM1, MGC4607/CCM2 and PDCD10/CCM3 in a large Italian family harbouring a Krit1/CCM1 mutation.
    Pileggi S; Buscone S; Ricci C; Patrosso MC; Marocchi A; Brunori P; Battistini S; Penco S
    J Mol Neurosci; 2010 Oct; 42(2):235-42. PubMed ID: 20419355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
    Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U
    Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
    Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
    J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.
    McDonald DA; Shi C; Shenkar R; Stockton RA; Liu F; Ginsberg MH; Marchuk DA; Awad IA
    Stroke; 2012 Feb; 43(2):571-4. PubMed ID: 22034008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of CCM1 induces hypersprouting and impairs response to flow.
    Mleynek TM; Chan AC; Redd M; Gibson CC; Davis CT; Shi DS; Chen T; Carter KL; Ling J; Blanco R; Gerhardt H; Whitehead K; Li DY
    Hum Mol Genet; 2014 Dec; 23(23):6223-34. PubMed ID: 24990152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation prevalence of cerebral cavernous malformation genes in Spanish patients.
    Mondéjar R; Solano F; Rubio R; Delgado M; Pérez-Sempere A; González-Meneses A; Vendrell T; Izquierdo G; Martinez-Mir A; Lucas M
    PLoS One; 2014; 9(1):e86286. PubMed ID: 24466005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.